Kentucky: Market and legal data analysis of the cannabis sector

18th April 2024: US - Kentucky: House Bill (HB) 829 has been signed by the governor. The bill will introduce some amendments to medical cannabis regulation, including registration and reporting requirements. HB 829 will also prohibit vaping cannabis on any form of public transport, in any public place, or in any form of public accommodation.
17th April 2024: US - Kentucky: House Bill (HB) 829 has been passed by the Senate and now heads to the governor. The bill would introduce some amendments to medical cannabis regulation, including registration and reporting requirements. HB 829 would also prohibit vaping cannabis on any form of public transport, in any public place, or in any form of public accommodation.
13th March 2024: US - Kentucky: House Bill (HB) 829 has been passed by the House and now heads to the Senate. The bill would introduce some amendments to medical cannabis regulation, including registration and reporting requirements. HB 829 would also prohibit vaping cannabis on any form of public transport, in any public place, or in any form of public accommodation.
8th January 2024: US - Kentucky: The Team Kentucky Medical Cannabis Workgroup has unanimously voted to recommend that the legislature add 15 qualifying conditions for medical cannabis to the current list. Senate Bill 47, which legalised medical cannabis for 7 medical conditions, is set to take effect on 1st January 2025.
13th November 2023: US - Kentucky: The General Assembly’s Administrative Regulations Review Subcommittee has approved an emergency rule to regulate hemp-derived cannabinoid products, press reports. The emergency rule was necessary to implement House Bill (HB) 544, which was passed earlier this year. Pursuant to HB 544, the emergency rule divides hemp cannabinoids into two distinct categories – adult-use and non-intoxicating – and places different requirements and restrictions on them. The emergency rule will be in effect until 27th April 2024, at which point a final rule must be approved.
3rd April 2023: US - Kentucky: Senate Bill (SB) 47 has been signed by the governor and enacted into law. SB 47 legalises using and possessing cannabis to treat people with certain medical conditions such as cancer, severe pain, epilepsy, multiple sclerosis, muscle spasms or spasticity, chronic nausea or cyclical vomiting, PTSD or any other medical condition or disease which the Kentucky Center for Cannabis deems appropriate. The bill establishes a medical cannabis access programme for qualified patients with authorisation from their physician, and exempts medical cannabis from state sales and excise taxes, though it specifies that smoking and home cultivation would remain prohibited.
31st March 2023: US - Kentucky: Senate Bill (SB) 47 has passed the House and now heads to the governor’s desk. SB 47 would legalise using and possessing cannabis to treat people with certain medical conditions such as cancer, severe pain, epilepsy, multiple sclerosis, muscle spasms or spasticity, chronic nausea or cyclical vomiting, PTSD or any other medical condition or disease which the Kentucky Center for Cannabis deems appropriate. The bill would establish a medical cannabis access programme for qualified patients with authorisation from their physician and exempt medical cannabis from the state sales and excise taxes, though it specifies that smoking and home cultivation would remain prohibited.
24th March 2023: US - Kentucky: House Bill (HB) 544 has been signed by the governor and enacted into law. HB 544 will set guidelines for the regulation of hemp-derived delta-8 THC products, including banning the sale and possession of delta-8 products to anyone younger than 21. The bill would also require new selling, labelling and testing requirements, and would direct the state Cabinet for Health and Family Services to establish administrative regulations for the production and sale of delta-8 products by 1st August 2023.
21st March 2023: US - Kentucky: House Bill 544 has been delivered to the governor for approval after being passed by the Senate. It would set guidelines for the regulation of hemp-derived delta-8 THC products, including banning their sale of delta-8 to under-21s. It also set new retail, labelling and testing requirements, and would direct the state Cabinet for Health and Family Services to establish administrative regulations for the production and sale of delta-8 products by 1st August.
20th March 2023: US - Kentucky: Senate Bill (SB) 47 has passed the Senate and now heads to the House. SB 47 would establish a medical cannabis programme for qualified patients with authorisation from their physician, specifying that smoking and home cultivation would remain prohibited. The bill would legalise the use and possession of medical cannabis to treat people with certain medical conditions such as cancer, severe pain, epilepsy, multiple sclerosis, muscle spasms or spasticity, chronic nausea or cyclical vomiting, PTSD or any other medical condition or disease which the Kentucky Center for Cannabis deems appropriate.
10th March 2023: US - Kentucky: House Bill (HB) 544 has passed the House and now moves to the Senate. HB 544 would set guidelines for the regulation of hemp-derived delta-8 THC products, including banning the sale of delta-8 products to anyone younger than 21. The bill would also require new selling, labelling and testing requirements, and would direct the state Cabinet for Health and Family Services to establish administrative regulations for the production and sale of delta-8 products by 1st August 2023.
16th November 2022: US - Kentucky: Governor Andy Beshear has issued two executive orders, one which allows for the possession of cannabis for medical purposes under certain conditions and another which regulates hemp-derived delta-8 THC products. The medical cannabis order grants pardons to anyone possessing cannabis after 1st January 2023 who demonstrates that a doctor has recommended it for a specified condition and that it was obtained legally in another state, among other conditions. The delta-8 THC order makes clear that “Delta-8 is not a controlled substance under either Kentucky law or federal law”, and applies the requirements of 902 KAR 45:190, which includes packaging and labelling requirements for hemp-derived products, to delta-8 products.

LATEST ALERTS

Cannabis and cannabinoids in Kentucky

Relaxation beats intoxication – IHDC sales aren’t just about getting high

US midterm elections: a look at the forecast outcomes and what’s at stake

Resistant legislators deny Kentucky and Tennessee access to medical cannabis

US medical cannabis products: a state-by-state regulatory report

Regulatory report: US state-by-state taxation of medical cannabis

Regulatory report: US state-by-state regulation of CBD vaping products

US regulatory tracker: state regulation of delta-8 THC, July

US regulatory tracker: proposed state laws, May

CBD product labelling – a US state-by-state analysis

Sign up to our newsletter

LATEST ALERTS

Cannabis and cannabinoids in Kentucky

Sign up to our newsletter

Start your FREE trial